Geistlich Pharma specialises in bone, cartilage and tissue regeneration using biomaterials. The company develops and manufactures medical devices and pharmaceuticals to improve patients’ quality of life.
Medical science distinguishes between two treatment methods: repair, which utilises artificial joints, and regeneration, which furthers healing of the body’s own tissue. The goal is to improve patients’ quality of life. At Geistlich Pharma, development of products in a sustainable, responsible way is of the utmost importance. Products are scientifically tested until they meet the company’s strict criteria for quality, safety and effectiveness.
The company’s products are marketed around the world through more than 50 business partners. It also has eight subsidiaries, located in Great Britain, Germany, Italy, France, China, Brazil, South Korea and North America.
Geistlich Pharma has about 425 employees worldwide. The company has shaped the regenerative biomaterials market for decades with its pioneering products Geistlich Bio-Oss® and Geistlich Bio-Gide®.